Charge Reversal of the Uppermost Arginine in Sliding Helix S4-I Affects Gating of Cardiac Sodium Channel
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020712 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Olga E Kulichik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Almazov National Medical Research Centre, 197341 St. Petersburg, Russia. Hauptthemen laut MEDLINE: NAV1.5 Voltage-Gated Sodium Channel, Arginine, Ion Channel Gating. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council, the Sechenov Institute of Evolutionary Physiology and Biochemistry Research Program, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Several mutations of the uppermost arginine, R219, in the voltage-sensing sliding helix S4I of cardiac sodium channel Nav1.5 are reported in the ClinVar databases, but the clinical significance of the respective variants is unknown (VUSs). AlphaFold 3 models predicted a significant downshift of S4I in the R219C VUS. Analogous downshift S4I, upon its in silico deactivation, resulted in a salt bridge between R219 and the uppermost glutamate, E161, in helix S2I. To understand how salt bridge elimination affects biophysical characteristics, we generated mutant channel R219E, expressed it in the HEK293-T cells, and employed the patch-clamp method in a whole-cell configuration. Mutation R219E did not change the peak current density but shortened time to the peak current at several potentials, significantly enhanced activation, enhanced steady-state inactivation and steady-state fast inactivation, and slowed recovery from inactivation. Taken together, these data suggest that mutation R219E destabilized the resting state of Nav1.5. Cardiac syndromes associated with mutations R219P/H/C/P or E161Q/K are consistent with the observed changes of biophysical characteristics of mutant channel R219E suggesting pathogenicity of the respective VUSs, as well as ClinVar-reported VUSs involving arginine or glutamate in homologous positions of several Nav1.5 paralogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.
- Sechenov Institute of Evolutionary Physiology & Biochemistry, Russian Academy of Sciences, 194223 St. Petersburg, Russia.
- Department of Women's and Children's Health and Center for Molecular Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden.
- Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4K1, Canada.
ORCID-Profile: Olga E Kulichik, Anna A Kostareva, Boris S Zhorov
Förderung
- Natural Sciences and Engineering Research Council
- the Sechenov Institute of Evolutionary Physiology and Biochemistry Research Program
- Natural Sciences and Engineering Research Council of Canada
- Sechenov Institute of Evolutionary Physiology and Biochemistry Research Program
Zitieren
APA
Kulichik, O. E., Zaytseva, A. K., Kostareva, A. A., & Zhorov, B. S. (2025). Charge Reversal of the Uppermost Arginine in Sliding Helix S4-I Affects Gating of Cardiac Sodium Channel. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020712
Vancouver
Kulichik OE, Zaytseva AK, Kostareva AA, Zhorov BS. Charge Reversal of the Uppermost Arginine in Sliding Helix S4-I Affects Gating of Cardiac Sodium Channel. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020712
BibTeX
@article{Kulichik2025,
author = {Kulichik, Olga E and Zaytseva, Anastasia K and Kostareva, Anna A and Zhorov, Boris S},
title = {Charge Reversal of the Uppermost Arginine in Sliding Helix S4-I Affects Gating of Cardiac Sodium Channel},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020712}
}
EUVIMED